학술논문

Single-cell mass cytometric analysis of peripheral immunity and multiplex plasma marker profiling of non-small cell lung cancer patients receiving PD-1 targeting immune checkpoint inhibitors in comparison with platinum-based chemotherapy.
Document Type
Article
Source
Frontiers in Immunology; 2023, p1-14, 14p
Subject
NON-small-cell lung carcinoma
PEMETREXED
IMMUNE checkpoint inhibitors
PROGRAMMED cell death 1 receptors
IMMUNE checkpoint proteins
CANCER patients
Language
ISSN
16643224
Abstract
Copyright of Frontiers in Immunology is the property of Frontiers Media S.A. and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)